2012The FASEB JournalRequires access

SUR2a gene is upregulated in skeletal muscle insulin resistance of obese rats: possible correlation with GLUT4 gene

Milano Felipe dos Santos Ferreira Marques, Rosana Cristina Tieko Mori, Maristela Mitiko Okamoto, Ubiratan Fabres Machado

Open publisher page 0 citations

Abstract

Objective The aim of this study was to investigate whether SUR2A (sulfonylurea receptor type 2A, ABCC9) MEF2a (myocyte enhancer factor‐2a) and HIF1a (Hypoxia‐inducible factor‐1) can influence glucose uptake in oxidative muscle soleus by regulating GLUT4 expression. Methods Insulin resistance was induced in male Wistar rats by inducing obesity with monosodium glutamate (MSG). At the age 3 months, half control and MSG‐treated animals started receiving 0.1 mg/kg/day of glimepiride in the drinking water, and distributed in 3 experimental groups: control rats (C), MSG‐obese rats (O) and MSG‐obese rats treated with glimepiride (OG). Animals were submitted to insulin tolerance test (ITT) and samples of soleus muscle were excised for quantification of gene expression by Real Time RT‐PCR and GLUT4 protein. Results OG rats presented a 51% increase in SUR2A mRNA content in comparison to O and C rats (p<0.001). O rats showed 16% increase in GLUT4 mRNA content (p<0.01 vs. C), without any increase in GLUT4 protein. After glimepiride treatment, OG rats increased GLUT4 mRNA (21%, p<0.01 vs. C) and protein (131%, p<0.01 vs. C; and 73%, p<0.05 vs. O). No significant differences (p>0.05) in mRNA expression of MEF2a and HIF1a were found. Conclusion We conclude that the glimepiride increased the GLUT4 expression in soleus of the insulin resistant animals which could be associated to SUR2A genes expression.

About this research paper

What this paper is about

Objective The aim of this study was to investigate whether SUR2A (sulfonylurea receptor type 2A, ABCC9) MEF2a (myocyte enhancer factor‐2a) and HIF1a (Hypoxia‐inducible factor‐1) can influence glucose uptake in oxidative muscle soleus by regulating GLUT4 expression. Methods Insulin resistance was induced in male Wistar rats by inducing obesity with monosodium glutamate (MSG). At the age 3 months, half control and MSG‐treated animals started receiving 0.1 mg/kg/day of glimepiride in the drinking water, and distributed in 3 experimental groups: control rats (C), MSG‐obese rats (O) and MSG‐obese rats treated with glimepiride (OG). Animals were submitted to insulin tolerance test (ITT) and samples of soleus muscle were excised for quantification of gene expression by Real Time RT‐PCR and GLUT4 protein. Results OG rats presented a 51% increase in SUR2A mRNA content in comparison to O and C rats (p<0.001). O rats showed 16% increase in GLUT4 mRNA content (p<0.01 vs. C), without any increase in GLUT4 protein. After glimepiride treatment, OG rats increased GLUT4 mRNA (21%, p<0.01 vs. C) and protein (131%, p<0.01 vs. C; and 73%, p<0.05 vs. O). No significant differences (p>0.05) in mRNA expression of MEF2a and HIF1a were found. Conclusion We conclude that the glimepiride increased the GLUT4 expression in soleus of the insulin resistant animals which could be associated to SUR2A genes expression.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective The aim of this study was to investigate whether SUR2A (sulfonylurea receptor type 2A, ABCC9) MEF2a (myocyte enhancer factor‐2a) and HIF1a (Hypoxia‐inducible factor‐1) can influence glucose uptake in oxidative muscle soleus by regulating GLUT4 expression. Methods Insulin resistance was induced in male Wistar rats by inducing obesity with monosodium glutamate (MSG). At the age 3 months, half control and MSG‐treated animals started receiving 0.1 mg/kg/day of glimepiride in the drinking water, and distributed in 3 experimental groups: control rats (C), MSG‐obese rats (O) and MSG‐obese rats treated with glimepiride (OG). Animals were submitted to insulin tolerance test (ITT) and samples of soleus muscle were excised for quantification of gene expression by Real Time RT‐PCR and GLUT4 protein. Results OG rats presented a 51% increase in SUR2A mRNA content in comparison to O and C rats (p<0.001). O rats showed 16% increase in GLUT4 mRNA content (p<0.01 vs. C), without any increase in GLUT4 protein. After glimepiride treatment, OG rats increased GLUT4 mRNA (21%, p<0.01 vs. C) and protein (131%, p<0.01 vs. C; and 73%, p<0.05 vs. O). No significant differences (p>0.05) in mRNA expression of MEF2a and HIF1a were found. Conclusion We conclude that the glimepiride increased the GLUT4 expression in soleus of the insulin resistant animals which could be associated to SUR2A genes expression.

Key concepts: GLUT4, Internal medicine, Endocrinology, Insulin resistance, Soleus muscle, Skeletal muscle, Glucose transporter, Glimepiride

Related papers

Back to paper searchBrowse research topicsOriginal source
SUR2a gene is upregulated in skeletal muscle insulin resistance of obese rats: possible correlation with GLUT4 gene — Research Paper | ScholarLens